Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomised Trial of Tenecteplase vs. Alteplase for Recanalisation in Acute Ischemic Stroke

Trial Profile

Randomised Trial of Tenecteplase vs. Alteplase for Recanalisation in Acute Ischemic Stroke

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 18 Apr 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tenecteplase (Primary) ; Alteplase
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms NOR-TEST

Most Recent Events

  • 01 May 2019 Post Hoc analysis results (n=348) assessing the rates of favorable outcome at 90 days, symptomatic intracerebral hemorrhage (sICH), and mortality after 7 and 90 days between tenecteplase and alteplase are published in the Stroke
  • 03 Jan 2019 Results of prespecified substudy of NOR-TEST assessing efficacy and safety of tenecteplase and alteplase in patients treated 3 to 4.5 hours after ischemic stroke, published in the Stroke.
  • 19 Jun 2018 Results of post-hoc analysis presented at the 4th Congress of the European Academy of Neurology.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top